Form 8-K - Current report:
SEC Accession No. 0001193125-24-001013
Filing Date
2024-01-03
Accepted
2024-01-03 07:06:58
Documents
14
Period of Report
2024-01-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d277393d8k.htm   iXBRL 8-K 25242
2 EX-99.1 d277393dex991.htm EX-99.1 22984
6 GRAPHIC g277393g0103035319803.jpg GRAPHIC 3441
  Complete submission text file 0001193125-24-001013.txt   186384

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ivvd-20240103.xsd EX-101.SCH 2837
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivvd-20240103_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivvd-20240103_pre.xml EX-101.PRE 11698
8 EXTRACTED XBRL INSTANCE DOCUMENT d277393d8k_htm.xml XML 3457
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 24504335
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)